Table 2.
Odds of using telehealth post COVID-19.
| Service | Telephone technology | Video technology | Video vs telephone technologies | |||||
|
|
ORa (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | ||
| Screening and assessment/intake | 3.06 (1.91-4.90) | <.001 | 5.49 (3.28-9.19) | <.001 | 1.79 (1.25-2.57) | .001 | ||
| Regular outpatient treatment | 4.01 (2.41-6.68) | <.001 | 6.98 (3.99-12.19) | <.001 | 1.74 (1.20-2.52) | .003 | ||
| Intensive outpatient treatment | 1.59 (1.02-2.48) | .04 | 3.85 (2.33-6.34) | <.001 | 2.42 (1.53-3.81) | <.001 | ||
| Residential therapy sessions | 1.87 (0.98-3.56) | .06 | 4.09 (2.04-8.22) | <.001 | 2.19 (1.26-3.83) | .006 | ||
| Case management | 3.74 (2.24-6.25) | <.001 | 5.12 (2.98-8.80) | <.001 | 1.37 (0.94-2.01) | .10 | ||
| Peer recovery supports | 4.06 (2.33-7.06) | <.001 | 4.31 (2.47-7.52) | <.001 | 1.06 (0.70-1.61) | .78 | ||
| Buprenorphine (Suboxone or Subutex) therapy | 1.18 (0.62-2.26) | .61 | 3.69 (1.81-7.55) | <.001 | 3.12 (1.68-5.81) | <.001 | ||
aOR: odds ratio.